PowerGrid Declared Successful Bidder for Interstate Transmission Project
Power Grid Corporation of India Limited (POWERGRID) has been declared a successful bidder for an Interstate Transmission System project. The…
ICICI Lombard Analyst/Investor Meeting Rescheduled to December 17, 2025
ICICI Lombard General Insurance Company Limited has announced the rescheduling of its analyst/institutional investor meeting. Originally…
Kaynes Technology Assigned CRISIL A/Watch Developing Rating
CRISIL Rating Limited has assigned a ‘CRISIL A/Watch Developing’ rating to the long-term bank facilities of Kaynes Technology…
Britannia Industries Senior Management Appointments Announced
Britannia Industries has announced the appointment of Mr. Abhishek Sinha as the Chief Sales Transformation Officer and Mr. Subhashis Basu as…
Can Fin Homes Declares Interim Dividend and Re-appoints Managing Director & CEO
Can Fin Homes has announced an interim dividend of ₹7.00 (350%) per equity share. The company has also approved the re-appointment of Shri…
SBI Appoints Ravi Ranjan as Managing Director, Effective December 15, 2025
State Bank of India (SBI) has announced the appointment of Shri Ravi Ranjan as Managing Director, effective December 15, 2025. He will hold…
Can Fin Homes Declares ₹7.00 Interim Dividend and Reappoints Managing Director
Can Fin Homes has announced an interim dividend of ₹7.00 (350%) per equity share for the financial year 2025-26. The record date for the…
RBL Bank CFO Buvanesh Tharashankar Resigns to Pursue External Opportunities
RBL Bank announces that Mr. Buvanesh Tharashankar, Chief Financial Officer (CFO), has resigned from his position to pursue opportunities…
DB Realty Clarification on Extra-Ordinary General Meeting Notice
DB Realty clarifies a typographical error in the Notice of the Extra-ordinary General Meeting (EGM) related to the proposed variation in the…
Zydus Lifesciences Sentynl Announces FDA Acceptance of CUTX-101 Resubmission
Sentynl Therapeutics, a Zydus Lifesciences subsidiary, announced the FDA’s acceptance of its New Drug Application (NDA) resubmission for…